logo
Select company
Select metric
-102.53%Cash Return on Invested Capital
VS
Market
7
Sector
21
Industry
29
History
27
$ 0.37Close
$ 0.29 - $ 4.28 52-Week Range
Ticker Information

Ticker

VYNE

Company Name

VYNE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VYNE THERAPEUTICS INC - Cash Return on Invested Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VYNE - CROIC Historical data
DateCash Return on Invested CapitalFree Cash FlowInvested Capital
6/30/2025-102.53%$ -39.89M$ 38.91M
3/31/2025-85.01%$ -37.57M$ 44.2M
12/31/2024-65.32%$ -34.09M$ 52.19M
9/30/2024-47.3%$ -30.11M$ 63.66M
6/30/2024-35.66%$ -26.75M$ 75.01M
3/31/2024-33.33%$ -27.84M$ 83.55M
12/31/2023-28.49%$ -25.34M$ 88.95M
9/30/2023-209.29%$ -24.08M$ 11.51M
6/30/2023-150.83%$ -26.05M$ 17.27M
3/31/2023-93.46%$ -24.7M$ 26.43M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VYNE THERAPEUTICS INC's latest trailing twelve months (TTM) CROIC stands at -151.36%.
  • Over the past 5 years, VYNE THERAPEUTICS INC's average CROIC has been -97.36%.
  • The median CROIC for VYNE THERAPEUTICS INC during this period was -93.52%
  • VYNE THERAPEUTICS INC reached its highest CROIC over the past 5 years at -28.49%.
  • The lowest CROIC recorded by VYNE THERAPEUTICS INC in the same timeframe -209.29%

VYNE THERAPEUTICS INC's CROIC vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CROIC Benchmarks
CompanyCROIC
ERNA : ERNEXA THERAPEUTICS INC -286.8%BRTX : BIORESTORATIVE THERAPIES INC -198.69%HCWB : HCW BIOLOGICS INC -188.65%LYRA : LYRA THERAPEUTICS INC -126.11%APRE : APREA THERAPEUTICS INC -94.98%AIM : AIM IMMUNOTECH INC -IBIO : IBIO INC -83.03%ADIL : ADIAL PHARMACEUTICALS INC -115.95%CELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC -83.1%DWTX : DOGWOOD THERAPEUTICS INC -224.65%

Definition of Cash Return on Invested Capital

[Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].
FCF / Inv. Capital
(=) CROIC
CROIC for VYNE THERAPEUTICS INC is calculated as follows: FCF [ $ -128.23M ] / Inv. Capital [ $ 84.72M ]
(=) CROIC [ -151.36% ]

VYNE - Cash Return on Invested Capital, Last 5 years

-209.29%

Minimum

Sep 30, 2023

-28.49%

Maximum

Dec 31, 2023

-97.36%

Average

-93.52%

Median

CROIC Benchmark Analysis

The chart above depicts the distribution of CROIC for companies in the Total Stock Market. The average CROIC of the companies is 2.84% with a standard deviation of 15.02%.
The following table provides additional summary stats:
CROIC in the Market:
filtered constituents3.46K
min-43.78%
max49.57%
average2.84%
median5.02%
std15.02%